Navigation Links
Novel protein found to enhance effect of Vitamin E and suppress prostate cancer

Researchers have identified a protein that disrupts an important signaling pathway in prostate cancer cells, thereby suppressing the tumor. The protein also enhances the retention of Vitamin E // that limits the proliferation of cancer cells.

The researchers of the present study are the first to describe the role of a protein known as alpha tocopherol associated protein or TAP in prostate cancer. Expression levels of TAP are significantly lower in prostate cancer than in a normal prostate.

Restoration of the levels of the protein in individuals with prostate cancer can be extended to have a therapeutic effect. The approach however would be technically very difficult. Therefore, the present practical solution is to investigate whether specific substances can increase the expression of TAP.

TAP is a binding protein that performs important cellular functions. The high levels of TAP in normal prostate cells suggest that TAP facilitates the transport of vitamin E into prostate tissue and helps retain high concentrations of the vitamin in the cells.

In prostate cancer cells, the researchers showed for the first time that TAP supports the retention of vitamin E. It was also found that TAP increases vitamin E's capacity to control the rapid growth of the cancer cells.

A cell can send messages from its surface to the nucleus through a set of chemical reactions known as a signaling pathway. The disruption of such a pathway by TAP has been found to suppress cancer cell growth. The pathway involves two proteins, phosphatidylinositol 3-kinase and constitutively active Akt, both of which play an important role in the initiation and progression of prostate cancer.

If research continues to show the important role of TAP, we could use TAP expression levels to better assess and predict the aggressiveness of the cancer. We may even be able to use TAP levels to predict whether a patient will respond to treatment.


'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: